Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein for the treatment of atopic dermatitis
2014-005593-11Phase 3Completed
- Sponsor
- University Hospital of Dermatology, Paracelsus Medical University
- Start
- Jan 2015
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of diacerein in atopic dermatitis (AD), sponsored by University Hospital of Dermatology, Paracelsus Medical University. Started Jan 2015; status: completed.
02
Drugs
diacerein
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2014-005593-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005593-11.